These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25609942)

  • 1. Symptoms and impact of COPD assessed by an electronic diary in patients with moderate-to-severe COPD: psychometric results from the SHINE study.
    Kulich K; Keininger DL; Tiplady B; Banerji D
    Int J Chron Obstruct Pulmon Dis; 2015; 10():79-94. PubMed ID: 25609942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Item selection, reliability and validity of the Shortness of Breath with Daily Activities (SOBDA) questionnaire: a new outcome measure for evaluating dyspnea in chronic obstructive pulmonary disease.
    Wilcox TK; Chen WH; Howard KA; Wiklund I; Brooks J; Watkins ML; Cates CE; Tabberer MM; Crim C
    Health Qual Life Outcomes; 2013 Nov; 11():196. PubMed ID: 24229361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analysis of four randomized clinical trials to confirm the reliability and responsiveness of the Shortness of Breath with Daily Activities (SOBDA) questionnaire in chronic obstructive pulmonary disease.
    Tabberer M; Brooks J; Wilcox T
    Health Qual Life Outcomes; 2015 Oct; 13():177. PubMed ID: 26520062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring respiratory symptoms of COPD: performance of the EXACT- Respiratory Symptoms Tool (E-RS) in three clinical trials.
    Leidy NK; Murray LT; Monz BU; Nelsen L; Goldman M; Jones PW; Dansie EJ; Sethi S
    Respir Res; 2014 Oct; 15(1):124. PubMed ID: 25287629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the psychometric properties of the Nighttime Symptoms of COPD Instrument.
    Mocarski M; Zaiser E; Trundell D; Make BJ; Hareendran A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():475-87. PubMed ID: 25834415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Changes in eDiary COPD Symptoms Predict Clinically Relevant Treatment Response at 12 Weeks: Analysis from the CRYSTAL Study.
    Kostikas K; Aalamian-Mattheis M; Pagano VA; Nunez X; Fogel R; Patalano F; Clemens A
    COPD; 2018 Apr; 15(2):185-191. PubMed ID: 29658810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study.
    LaForce C; Feldman G; Spangenthal S; Eckert JH; Henley M; Patalano F; D'Andrea P
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1233-43. PubMed ID: 27354782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional assessment of the burden of COPD symptoms in the US and Europe using the National Health and Wellness Survey.
    Ding B; DiBonaventura M; Karlsson N; Bergström G; Holmgren U
    Int J Chron Obstruct Pulmon Dis; 2017; 12():529-539. PubMed ID: 28223793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease awareness in patients with COPD: measurement and extent.
    Baiardini I; Rogliani P; Santus P; Corsico AG; Contoli M; Scichilone N; Di Marco F; Lessi P; Scognamillo C; Molinengo G; Ferri F; Patella V; Fiorentino G; Carone M; Braido F
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1-11. PubMed ID: 30587957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of the chronic obstructive pulmonary disease morning symptom diary (COPD-MSD).
    Globe G; Currie B; Leidy NK; Jones P; Mannino D; Martinez F; Klekotka P; O'Quinn S; Karlsson N; Wiklund I
    Health Qual Life Outcomes; 2016 Jul; 14(1):104. PubMed ID: 27424173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study.
    Oga T; Tsukino M; Hajiro T; Ikeda A; Nishimura K
    Respir Res; 2012 Sep; 13(1):85. PubMed ID: 23006638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of glycopyrrolate in patients with COPD by reversibility: pooled analysis of GEM1 and GEM2 12-week studies.
    Ohar JA; Bowling A; Goodin T; Price B; Ozol-Godfrey A; Sharma S; Sanjar S
    Int J Chron Obstruct Pulmon Dis; 2019; 14():461-470. PubMed ID: 30863047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the psychometric properties of the Early Morning Symptoms of COPD Instrument (EMSCI).
    Hareendran A; Make BJ; Zaiser E; Garcia Gil E
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1633-1645. PubMed ID: 29849455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the French version of the London Chest Activity of Daily Living scale and the Dyspnea-12 questionnaire.
    Beaumont M; Couturaud F; Jego F; Pichon R; Le Ber C; Péran L; Rogé C; Renault D; Narayan S; Reychler G
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1399-1405. PubMed ID: 29750026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity, reliability, and responsiveness of a new short Visual Simplified Respiratory Questionnaire (VSRQ) for health-related quality of life assessment in chronic obstructive pulmonary disease.
    Perez T; Arnould B; Grosbois JM; Bosch V; Guillemin I; Bravo ML; Brun M; Tonnel AB;
    Int J Chron Obstruct Pulmon Dis; 2009; 4():9-18. PubMed ID: 19436682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity.
    Lee H; Jhun BW; Cho J; Yoo KH; Lee JH; Kim DK; Lee JD; Jung KS; Lee JY; Park HY
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3301-3310. PubMed ID: 29180860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new functional status outcome measure of dyspnea and anxiety for adults with lung disease: the dyspnea management questionnaire.
    Migliore Norweg A; Whiteson J; Demetis S; Rey M
    J Cardiopulm Rehabil; 2006; 26(6):395-404. PubMed ID: 17135861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the impact of morning symptoms in COPD using the Capacity of Daily Living during the Morning (CDLM) questionnaire.
    Núñez A; Esquinas C; Barrecheguren M; Calle M; Casamor R; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3837-3844. PubMed ID: 30538445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study.
    Wang C; Sun T; Huang Y; Humphries M; Bai L; Li L; Wang Q; Kho P; Firth R; D'Andrea P
    Int J Chron Obstruct Pulmon Dis; 2015; 10():57-68. PubMed ID: 25609940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between objectively measured physical activity and morning symptoms in COPD.
    van Buul AR; Kasteleyn MJ; Chavannes NH; Taube C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2831-2840. PubMed ID: 29042764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.